fbpx
November 25, 2022

FDA Rejects Piziotinib for Certain Types of NSCLC FDA Rejects Piziotinib for Certain Types of NSCLC

The US Food and Drug Administration (FDA) has announced that it will not approve poziotinib (Spectrum Pharmaceuticals) for the treatment of certain patients with nonsmall-cell lung […]
November 23, 2022

FDA Approves First Gene Therapy for Hemophilia B FDA Approves First Gene Therapy for Hemophilia B

The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (EtranaDez), the first gene therapy option for adults with hemophilia B who currently use factor IX prophylaxis therapy, […]
November 22, 2022

FDA Alert: ‘Substantial’ Hypocalcemia Risk with Prolia Use FDA Alert: ‘Substantial’ Hypocalcemia Risk with Prolia Use

The US Food and Drug Administration (FDA) issued an alert today that cited preliminary evidence for a “substantial risk” for severe and symptomatic hypocalcemia and serious […]
November 18, 2022

FDA Approves First-Ever Agent to Delay Type 1 Diabetes Onset FDA Approves First-Ever Agent to Delay Type 1 Diabetes Onset

The US Food and Drug Administration has approved the anti-CD3 monoclonal antibody teplizumab-mzwv (Tzield, Provention Bio) to delay the onset of clinical type 1 diabetes in […]
November 10, 2022

Anti-Vax Doctor Simone Gold Sued by Organization She Founded Anti-Vax Doctor Simone Gold Sued by Organization She Founded

America’s Frontline Doctors is suing one of its founders in a battle for control over the controversial group, which gained national notoriety for spreading misinformation about […]
November 9, 2022

Marijuana Use Increased During Pandemic: Study Marijuana Use Increased During Pandemic: Study

Marijuana use increased significantly during the pandemic in states where it is illegal and in states where medical marijuana is legal, according to a new study. […]
November 4, 2022

FDA Expands Vemlidy Use to Adolescents With Chronic HBV FDA Expands Vemlidy Use to Adolescents With Chronic HBV

The US Food and Drug Administration (FDA) has expanded the indication for tenofovir alafenamide (Vemlidy) to children aged 12 years and older with chronic hepatitis B […]
October 25, 2022

FDA OKs Teclistamab for Relapsed/Refractory Multiple Myeloma FDA OKs Teclistamab for Relapsed/Refractory Multiple Myeloma

The US Food and Drug Administration (FDA) has granted accelerated approval to teclistamab (Tecvayli, Janssen Biotech, Inc.) for adults with relapsed or refractory multiple myeloma after […]
October 24, 2022

FDA Approves New Immunotherapy Combo for Liver Cancer FDA Approves New Immunotherapy Combo for Liver Cancer

The US Food and Drug Administration (FDA) has approved a new immunotherapy combination for use in the treatment of unresectable hepatocellular carcinoma (HCC), the most common […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0